Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
1.240
+0.040 (3.33%)
Oct 24, 2025, 4:00 PM EDT - Market closed

Liminatus Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21
348075349337
Market Cap Growth
-77.13%6.12%-78.38%3.48%-
Enterprise Value
349787362-
Last Close Price
1.2411.2210.3310.129.78
PB Ratio
--4.14-4.78-32.30-29.64
Debt / Equity Ratio
-0.16-1.03-1.02-1.53-1.16
Quick Ratio
0.130.000.030.290.00
Current Ratio
0.170.210.120.390.19
Return on Assets (ROA)
--54.41%-66.30%-35.51%-
Return on Capital (ROIC)
--468.22%-101.31%-45.20%-
Earnings Yield
-3.11%-4.43%-6.60%-0.84%-1.66%
Buyback Yield / Dilution
-28.19%-9.49%-188.25%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q